Literature DB >> 21883133

Using penalised logistic regression to fine map HLA variants for rheumatoid arthritis.

Charlotte M Vignal1, Aruna T Bansal, David J Balding.   

Abstract

Rheumatoid arthritis (RA) is strongly associated with the human leukocyte antigen (HLA) genomic region, most notably with a group of HLA-DRB1 alleles termed the shared epitope (SE). There is also substantial evidence of other risk loci in the HLA region, but refinement has been hampered by extensive linkage disequilibrium (LD). Using genotype imputation, we analysed 6575 RA cases and controls with genotypes at 6180 HLA SNPs; about half the subjects had four-digit DRB1 genotypes. Single-SNP tests revealed hundreds of strong associations across the HLA region, even after adjusting for DRB1. We implemented penalised logistic regression in a multi-SNP association analysis using the double-exponential (DE) penalty term on the regression coefficients and the normal-exponential-gamma (NEG). The penalised approaches identified sparse sets of SNPs that could collectively explain most of the association with RA over the whole HLA region. The HLA-DPB1 SNP rs3117225, was consistently identified in our analyses and was confirmed by results from the North American Rheumatoid Arthritis Consortium study (NARAC). We conclude that SNP selection using penalised regression shows a substantial benefit over single-SNP analyses in identifying risk loci in regions of high LD, and the flexibility of the NEG conveys additional advantages.
© 2011 The Authors Annals of Human Genetics © 2011 Blackwell Publishing Ltd/University College London.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883133     DOI: 10.1111/j.1469-1809.2011.00670.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  14 in total

1.  Comparison of Nonlinear Mixed Effects Models and Noncompartmental Approaches in Detecting Pharmacogenetic Covariates.

Authors:  Adrien Tessier; Julie Bertrand; Marylore Chenel; Emmanuelle Comets
Journal:  AAPS J       Date:  2015-02-20       Impact factor: 4.009

Review 2.  An introduction to machine learning and analysis of its use in rheumatic diseases.

Authors:  Kathryn M Kingsmore; Christopher E Puglisi; Amrie C Grammer; Peter E Lipsky
Journal:  Nat Rev Rheumatol       Date:  2021-11-02       Impact factor: 20.543

3.  PUMA: a unified framework for penalized multiple regression analysis of GWAS data.

Authors:  Gabriel E Hoffman; Benjamin A Logsdon; Jason G Mezey
Journal:  PLoS Comput Biol       Date:  2013-06-27       Impact factor: 4.475

4.  Integrating dynamic mixed-effect modelling and penalized regression to explore genetic association with pharmacokinetics.

Authors:  Julie Bertrand; Maria De Iorio; David J Balding
Journal:  Pharmacogenet Genomics       Date:  2015-05       Impact factor: 2.089

5.  Novel bayes factors that capture expert uncertainty in prior density specification in genetic association studies.

Authors:  Amy V Spencer; Angela Cox; Wei-Yu Lin; Douglas F Easton; Kyriaki Michailidou; Kevin Walters
Journal:  Genet Epidemiol       Date:  2015-02-27       Impact factor: 2.135

6.  Host genetics and immune control of HIV-1 infection: fine mapping for the extended human MHC region in an African cohort.

Authors:  H A Prentice; N M Pajewski; D He; K Zhang; E E Brown; W Kilembe; S Allen; E Hunter; R A Kaslow; J Tang
Journal:  Genes Immun       Date:  2014-05-01       Impact factor: 2.676

7.  Conditional analysis identifies three novel major histocompatibility complex loci associated with psoriasis.

Authors:  Jo Knight; Sarah L Spain; Francesca Capon; Adrian Hayday; Frank O Nestle; Alex Clop; Jonathan N Barker; Michael E Weale; Richard C Trembath
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

8.  Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA).

Authors:  Ebun Omoyinmi; Paola Forabosco; Raja Hamaoui; Annette Bryant; Anne Hinks; Simona Ursu; Lucy R Wedderburn; Wendy Thomson; Cathryn M Lewis; Patricia Woo
Journal:  PLoS One       Date:  2012-10-18       Impact factor: 3.240

9.  Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.

Authors:  Luis G Carvajal-Carmona; Tracy A O'Mara; Jodie N Painter; Felicity A Lose; Joe Dennis; Kyriaki Michailidou; Jonathan P Tyrer; Shahana Ahmed; Kaltin Ferguson; Catherine S Healey; Karen Pooley; Jonathan Beesley; Timothy Cheng; Angela Jones; Kimberley Howarth; Lynn Martin; Maggie Gorman; Shirley Hodgson; Nicholas Wentzensen; Peter A Fasching; Alexander Hein; Matthias W Beckmann; Stefan P Renner; Thilo Dörk; Peter Hillemanns; Matthias Dürst; Ingo Runnebaum; Diether Lambrechts; Lieve Coenegrachts; Stefanie Schrauwen; Frederic Amant; Boris Winterhoff; Sean C Dowdy; Ellen L Goode; Attila Teoman; Helga B Salvesen; Jone Trovik; Tormund S Njolstad; Henrica M J Werner; Rodney J Scott; Katie Ashton; Tony Proietto; Geoffrey Otton; Ofra Wersäll; Miriam Mints; Emma Tham; Per Hall; Kamila Czene; Jianjun Liu; Jingmei Li; John L Hopper; Melissa C Southey; Arif B Ekici; Matthias Ruebner; Nichola Johnson; Julian Peto; Barbara Burwinkel; Frederik Marme; Hermann Brenner; Aida K Dieffenbach; Alfons Meindl; Hiltrud Brauch; Annika Lindblom; Jeroen Depreeuw; Matthieu Moisse; Jenny Chang-Claude; Anja Rudolph; Fergus J Couch; Janet E Olson; Graham G Giles; Fiona Bruinsma; Julie M Cunningham; Brooke L Fridley; Anne-Lise Børresen-Dale; Vessela N Kristensen; Angela Cox; Anthony J Swerdlow; Nicholas Orr; Manjeet K Bolla; Qin Wang; Rachel Palmieri Weber; Zhihua Chen; Mitul Shah; Paul D P Pharoah; Alison M Dunning; Ian Tomlinson; Douglas F Easton; Amanda B Spurdle; Deborah J Thompson
Journal:  Hum Genet       Date:  2014-12-09       Impact factor: 4.132

10.  Weibull regression with Bayesian variable selection to identify prognostic tumour markers of breast cancer survival.

Authors:  P J Newcombe; H Raza Ali; F M Blows; E Provenzano; P D Pharoah; C Caldas; S Richardson
Journal:  Stat Methods Med Res       Date:  2016-09-30       Impact factor: 3.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.